PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview

被引：6
|
作者：
Caracciolo, Matteo [1 ]
Castello, Angelo [2 ]
Lopci, Egesta [3 ,4 ]
机构：
[1] Univ Hosp Ferrara, Oncol Med & Specialists Dept, Nucl Med Unit, Ferrara, Italy
[2] Fdn IRCCS CaGranda, Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
[3] IRCCS, Human Res Hosp, Nucl Med Unit, Milan, Italy
[4] IRCCS, Human Res Hosp, Nucl Med Unit, Via Manzoni 56, I-20089 Milan, Italy
来源：
SEMINARS IN NUCLEAR MEDICINE | 2024年 / 54卷 / 01期
关键词：
GA-68-PSMA PET/CT; DIAGNOSTIC-ACCURACY; BIOPSY; VALIDATION; MRI; PSA;
D O I：
10.1053/j.semnuclmed.2023.10.002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
In the last years, PSMA-PET imaging and multiparametric MRI (mpMRI) have improved the clinical management of prostate cancer (PCa) patients. Currently, mpMRI is recommended by the EAU (European Association of Urology) guidelines for the primary diagnosis of PCa, whereas PSMA-PET is reserved for disease staging, particularly in high risk localized or locally advanced disease, as well as for biochemical recurrence after surgery. Nevertheless, several studies have explored the added value of PSMA-PET in other clinical scenar-ios, including primary diagnosis and especially for the detection of clinically significant PCa (csPCa). In the present contribution, we will provide an overview and an update on the cur-rent literature on imaging detection of csPCa, with a particular focus on mpMRI, PSMA-PET and their comparison. Semin Nucl Med 54:30-38 (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：30 / 38
页数：9
相关论文
共 50 条
  • [1] Comparison of MRI, PSMA PET/CT, and Fusion PSMA PET/MRI for Detection of Clinically Significant Prostate Cancer
    Arslan, Aydan
    Karaarslan, Ercan
    Guner, A. Levent
    Saglican, Yesim
    Tuna, Mustafa Bilal
    Ozisik, Ozan
    Kural, Ali Riza
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2021, 45 (02) : 210 - 217
  • [2] PSMA PET/CT for Primary Staging of Prostate Cancer- An Updated Overview
    Jochumsen, Mads Ryo
    Bouchelouche, Kirsten
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 39 - 45
  • [3] Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer
    Prive, Bastiaan M.
    Israel, Bas
    Janssen, Marcel J. R.
    van der Leest, Marloes M. G.
    de Rooij, Maarten
    van Ipenburg, Jolique A.
    Jonker, Marianne
    Peters, Steffie M. B.
    de Groot, Michel
    Zamecnik, Patrik
    Hoepping, Alexander
    Bomers, Joyce G.
    Gotthardt, Martin
    Sedelaar, J. P. Michiel
    Barentsz, Jelle O.
    van Oort, Inge M.
    Nagarajah, James
    RADIOLOGY, 2024, 311 (02)
  • [4] Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI
    Pepe, Pietro
    Pennisi, Michele
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : 639 - 642
  • [5] Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer
    Meyer, Alexa R.
    Joice, Gregory A.
    Allaf, Mohamad E.
    Rowe, Steven P.
    Gorin, Michael A.
    CURRENT OPINION IN UROLOGY, 2018, 28 (06) : 493 - 498
  • [6] 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis
    Barnett, Christine L.
    Davenport, Matthew S.
    Montgomery, Jeffrey S.
    Kunju, Lakshmi Priya
    Denton, Brian T.
    Piert, Morand
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (12) : 1705 - 1712
  • [7] Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer
    Kesch, Claudia
    Radtke, Jan-Philipp
    Wintsche, Axel
    Wiesenfarth, Manuel
    Luttje, Mariska
    Gasch, Claudia
    Dieffenbacher, Svenja
    Pecqueux, Carine
    Teber, Dogu
    Hatiboglu, Gencay
    Nyarangi-Dix, Joanne
    Simpfendoerfer, Tobias
    Schoenberg, Gita
    Dimitrakopoulou-Strauss, Antonia
    Freitag, Martin
    Duensing, Anette
    Gruellich, Carsten
    Jaeger, Dirk
    Goetz, Michael
    Grabe, Niels
    Schweiger, Michal-Ruth
    Pahernik, Sascha
    Perner, Sven
    Herpel, Esther
    Roth, Wilfried
    Wieczorek, Kathrin
    Maier-Hein, Klaus
    Debus, Jurgen
    Haberkorn, Uwe
    Giesel, Frederik
    Galle, Joerg
    Hadaschik, Boris
    Schlemmer, Heinz-Peter
    Hohenfellner, Markus
    Bonekamp, David
    Sueltmann, Holger
    Duensing, Stefan
    SCIENTIFIC REPORTS, 2018, 8
  • [8] Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
    Demirci, Emre
    Kabasakal, Levent
    Sahin, Onur E.
    Akgun, Elife
    Gultekin, Mehmet Hamza
    Doganca, Tunkut
    Tuna, Mustafa B.
    Obek, Can
    Kilic, Mert
    Esen, Tarik
    Kural, Ali R.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (01) : 86 - 91
  • [9] Irreversible electroporation for prostate cancer using PSMA PET-CT
    Shin, Dongho
    Yoon, Chang Eil
    Kwon, Hyeok Jae
    Park, Yong Hyun
    Cho, Hyuk Jin
    Ha, U-syn
    Hong, Sung-Hoo
    Park, Sonya Youngju
    Ha, Seunggyun
    O, Joo Hyun
    Yoo, Ie Ryung
    Park, Chansoo
    Chi, Dae Yoon
    Lee, Ji Youl
    PROSTATE INTERNATIONAL, 2023, 11 (01) : 40 - 45
  • [10] Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
    Pepe, Pietro
    Pepe, Ludovica
    Tamburo, Maria
    Marletta, Giulia
    Pennisi, Michele
    Fraggetta, Filippo
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2022, 94 (03) : 274 - 277
12345